Charles River is excited to participate in the 12th International Society for the Study of Xenobiotics (ISSX) Meeting. ISSX brings together a network of academics, research scientists, and future scientists in toxicology, pharmacology, molecular biology, and other disciplines related to the study of xenobiotics.
Xenobiotic drug metabolism is an important and crucial determinant of the pharmacokinetic behavior of any drug. As part of our breadth of services, Charles River offers a complete package of ADME programs, both in vitro and in vivo, for drugs, agrochemicals, and veterinary products.
Visit Booth 408/410 to learn how Charles River and SOLVO Biotechnology, now combined, can help support you and expedite your time to market. To schedule a meeting with our specialists, contact us at [email protected].
In addition to exhibiting, Charles River is pleased to be participating in this meeting with the following presentations:
Tuesday, July 30th, 12:00PM – 1:00PM
Evaluation of Single-Use Rapid Equilibrium Dialysis (RED) Device for Automated Octanol-Water Partitioning (LOGD7.4) Assay to Assess the Lipophilicity of Drug Compounds
Sarah Meloche, Jakal Amin, and Adrian Sheldon; Charles River
Wednesday, July 31st, 1:30PM – 2:30PM
Assay Calibration to Refine Prediction of OATP1B1/1B3 Mediated Drug-Drug Interactions (DDI) Based on In Vitro Uptake Transport Assay Data
Zsuzsanna Gaborik, SOLVO Biotechnology